US Supreme Court Decision on Patenting of Genomic DNA

The US Supreme Court, in a nearly unanimous ruling (Scalia joined the majority for most of the decision), has held that a piece of DNA that occurs naturally is not eligible for patenting. This means that any sequences that are normally present in the human genome—or that of any other organism—cannot be the subject of patent infringement.

You can find the complete article at the following address:

Leave a Reply

Your email address will not be published. Required fields are marked *